Aurobindo Pharma


'Aurobindo Pharma' - 15 Video Result(s)

'Aurobindo Pharma' - 276 News Result(s)

  • Pharma Stocks Outperform; Lupin, Sun Pharma Rise 2%

    Pharma Stocks Outperform; Lupin, Sun Pharma Rise 2%

    Shares of pharmaceutical companies such as Lupin, Sun Pharmaceuticals, Dr Reddy's Laboratories and Aurobindo Pharma outperformed today in an otherwise subdued market.

  • Every Dip Buying Opportunity, Go Long In GAIL India, IGL: Ruchit Jain

    Every Dip Buying Opportunity, Go Long In GAIL India, IGL: Ruchit Jain

    Buying in Nifty on Wednesday emerged once it went closer to its support zone of 8,060 which suggest that there are no reversal signs and indicates that Nifty would not correct significantly from current levels, says Ruchit Jain, equity technical analyst with Angel Broking.

  • Investment Board Refers Holcim Proposal To Cabinet For Approval

    Investment Board Refers Holcim Proposal To Cabinet For Approval

    Inter-ministerial body FIPB has referred the Rs 3,400-crore foreign investment proposal of Holcim (India) to the Cabinet Committee on Economic Affairs for approval, while deferred the decision on Vodafone's application for acquisition of You Broadband India.

  • Buy Jet Airways, ONGC; Avoid Aurobindo Pharma: Ruchit Jain

    Buy Jet Airways, ONGC; Avoid Aurobindo Pharma: Ruchit Jain

    Nifty is trading near important technical levels and it is better to book profits on the positions taken at lower levels rather than going long, says Ruchit Jain, equity technical analyst with Angel Broking.

  • Aurobindo Pharma Fourth Quarter Profit Jumps 40%; Shares Rise 4%

    Aurobindo Pharma Fourth Quarter Profit Jumps 40%; Shares Rise 4%

    Aurobindo Pharma Ltd, India's fourth-largest drugmaker by sales, said higher sales in the United States and emerging markets helped its fourth-quarter net profit grow 40 per cent, above estimates, sending shares up as much as 4 per cent.

  • Aurobindo Pharma Posts Profit Of Rs 563 Crore In Q4

    Aurobindo Pharma Posts Profit Of Rs 563 Crore In Q4

    Drug maker Aurobindo Pharma on Monday posted a consolidated net profit of Rs 562.85 crore for the fiscal fourth quarter that ended on March 31, 2016.

  • Cabinet To Decide On Axis Bank Rs 12,973 Crore Foreign Investment Proposal

    Cabinet To Decide On Axis Bank Rs 12,973 Crore Foreign Investment Proposal

    The Cabinet Committee on Economic Affairs will take a final call on Axis Bank's Rs 12,973-crore foreign investment proposal, the Finance Ministry said on Wednesday.

  • Aurobindo Gets USFDA Nod For Opioid Analgesic Tablets

    Aurobindo Gets USFDA Nod For Opioid Analgesic Tablets

    Aurobindo Pharma has received final approval from the US health regulator to manufacture and market opioid analgesic Hydromorphone Hydrochloride tablets in the American market.

  • Aurobindo Pharma Gets USFDA Nod For Anaesthetic Injection

    Aurobindo Pharma Gets USFDA Nod For Anaesthetic Injection

    Aurobindo Pharma has received final nod from the US health regulator to manufacture and market its anaesthetic Bupivacaine Hydrochloride injection in the American market.

  • Aurobindo Pharma Gets USFDA Nod For Generic Migraine Drug

    Aurobindo Pharma Gets USFDA Nod For Generic Migraine Drug

    Aurobindo Pharma has received approval from the US health regulator to sell generic Zolmitriptan tablets, a drug used to treat migraine, in the American market.

  • Aurobindo Pharma Gets Final USFDA Nod For Cholesterol Drug

    Aurobindo Pharma Gets Final USFDA Nod For Cholesterol Drug

    According to IMS, the approved product has an estimated market size of $412 million for the twelve months ended March 2016, Aurobindo Pharma said.

  • Nifty Unlikely To Fall Below 7,500, Buy TVS Motor: Shahina Mukadam

    Nifty Unlikely To Fall Below 7,500, Buy TVS Motor: Shahina Mukadam

    Domestic equities have been pressured by events in the international markets, making bulls a bit nervous, says market expert Shahina Mukadam. Stocks like Reliance Industries, ICICI Bank and other banking shares as a whole are contributing to the fall and keeping markets subdued, she added.

  • Aurobindo Gets US Nod For Seizures Treatment Drug

    Aurobindo Gets US Nod For Seizures Treatment Drug

    Aurobindo Pharma has received final approval from the US health regulator for its Lacosamide tablets used for treatment of partial-onset seizures in American market.

  • Aurobindo Pharma Gets USFDA Nod For Two Drugs

    Aurobindo Pharma Gets USFDA Nod For Two Drugs

    Aurobindo Pharma on Wednesday said it has received final approval from the US health regulator to manufacture and market generic version of heartburn relief medicine Famotidine tablets.

  • Aurobindo Pharma Gets USFDA Nod For Blood Pressure Drug

    Aurobindo Pharma Gets USFDA Nod For Blood Pressure Drug

    Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market generic version of blood pressure treatment drugs Amlodipine and Valsartan tablets.

................................ Advertisement ................................

................................ Advertisement ................................